Matan Geron's Avatar

Matan Geron

@mgeron.bsky.social

Postdoc in the Scherrer lab at UNC-Chapel Hill studying pain and opioids

242 Followers  |  261 Following  |  3 Posts  |  Joined: 18.11.2024  |  1.5122

Latest posts by mgeron.bsky.social on Bluesky

Preview
Painkillers without the addiction? The new wave of non-opioid pain relief Pharma firms are developing drugs that avoid the brainโ€™s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

In January, the FDA approved a new non-opioid painkiller. CBP's Grรฉgory Scherrer spoke with @theguardian.com about the new wave of developing non-opioid drugs for pain relief. Read here: www.theguardian.com/science/2025...

09.04.2025 18:54 โ€” ๐Ÿ‘ 5    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
A DREADD for the periphery - Nature Methods Nature Methods - A DREADD for the periphery

www.nature.com/articles/s41...

Nice blurb on our recent paper!

11.02.2025 20:57 โ€” ๐Ÿ‘ 5    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Structure-guided design of a peripherally restricted chemogenetic system Kang etย al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice. This system will enable the study of peripheral physiology without affecting the central nervous system.

Kang etย al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice.
www.cell.com/cell/fulltex...

02.01.2025 12:47 โ€” ๐Ÿ‘ 2    ๐Ÿ” 3    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Gene Therapy Breakthrough Targets Peripheral Pain Pain is meant to be a defense mechanism. It creates a strong sensation to get us to respond to a stimulus and prevent ourselves from further harm

New from Rothlab!
www.miragenews.com/gene-therapy...

17.12.2024 22:41 โ€” ๐Ÿ‘ 6    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Please add me

11.12.2024 01:05 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Structure-guided design of a peripherally restricted chemogenetic system Kang etย al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice. This system will enable the study of peripheral physiology without affecting the central nervous system.

I am glad to share our recent work, now published in Cell! A @zenbrainest.bsky.social and Scherrer lab collaboration developing and validating a new peripherally restricted DREADD system! Great team work with Hye Jin Kang, Brian Krumm, @adrtas.bsky.social, and others
www.cell.com/cell/abstrac...

07.12.2024 01:41 โ€” ๐Ÿ‘ 14    ๐Ÿ” 6    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

New paper from the lab:
Structure-guided design of a peripherally restricted chemogenetic system
10.1016/j.cell.2024.11.001

03.12.2024 17:54 โ€” ๐Ÿ‘ 1    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Could you please add me? Thank you

20.11.2024 01:01 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

I started (at @katesadlerphd.bsky.social's suggestion, thanks Kate for pushing me) a pain neuroscience and pain research starter pack. I am sure I have missed many people so if I missed you, I am sorry, but please just ask me to add you in the thread below and I will do that. go.bsky.app/KboKNhg

18.11.2024 16:58 โ€” ๐Ÿ‘ 63    ๐Ÿ” 28    ๐Ÿ’ฌ 38    ๐Ÿ“Œ 1

@mgeron is following 20 prominent accounts